Diagnostic Accuracy of Glial Fibrillary Acidic Protein and Ubiquitin Carboxy-Terminal Hydrolase-L1 Serum Concentrations for Differentiating Acute Intracerebral Hemorrhage from Ischemic Stroke.
Sebastian LugerHenriette S JægerJoanna DixonFerdinand O BohmannJanHendrik SchaeferSteven P RichieriKarianne LarsenMaren R HovKristi G BacheChristian Foerchnull nullPublished in: Neurocritical care (2021)
GFAP may differentiate ICH from ischemic stroke and stroke mimics. A point-of-care test to distinguish between ischemic and hemorrhagic strokes might facilitate triage to different treatment pathways or locations, or be used to select patients for trials of ultra-early interventions.
Keyphrases
- atrial fibrillation
- end stage renal disease
- emergency department
- newly diagnosed
- chronic kidney disease
- ejection fraction
- liver failure
- physical activity
- brain injury
- prognostic factors
- peritoneal dialysis
- respiratory failure
- high resolution
- small molecule
- spinal cord injury
- patient reported outcomes
- magnetic resonance imaging
- intensive care unit
- drug induced
- ionic liquid
- computed tomography
- neuropathic pain
- cerebral ischemia
- hepatitis b virus
- blood brain barrier
- subarachnoid hemorrhage